Skip to main content
Clinical Trials/IRCT2017060117756N16
IRCT2017060117756N16
Completed
Phase 2

A comparative study of the effects of intralesional Meglumine Antimonate injection alone and intralesional Meglumine Antimonate injection plus local barberry root extract on improvement of skin lesions of patients with cutaneous leishmaniasis

Vice-chancellery for Research of Mashhad University of Medicla Sciences0 sites40 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
cutaneous leishmaniasis.
Sponsor
Vice-chancellery for Research of Mashhad University of Medicla Sciences
Enrollment
40
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Vice-chancellery for Research of Mashhad University of Medicla Sciences

Eligibility Criteria

Inclusion Criteria

  • Positive direct smear in terms of Leishman\-Donovan body; time passed less than 6 months from legion onset; no other treatment received for leishmaniasis during the last three months; informed consent for participation; lesion located is in upper limbs or the face.
  • Exclusion criteria: Allergy to Meglumine (severe local reactions or anaphylaxis) or topical compounds used; irregular visits; incidence of secondary infection of the lesions based on clinical features and the therapist’s judgment ; presence of systemic treatment indications for cutaneous leishmaniosis including lesions on joints, number of lesions more than or equal to 5, lesion size more than or equal to 5 cm.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials